One fi­nal push: EU phar­ma in­dus­try group de­mands com­pe­ti­tion check on in­com­ing leg­isla­tive over­haul

The Brus­sels-based Eu­ro­pean Fed­er­a­tion of Phar­ma­ceu­ti­cal In­dus­tries and As­so­ci­a­tions (EF­PIA) this morn­ing called on the Eu­ro­pean Com­mis­sion to en­sure that it ad­e­quate­ly as­sess­es how its re-writ­ing of the 20+-year-old phar­ma leg­is­la­tion, which is due to be re­leased be­fore the end of the month, dam­ages the com­pet­i­tive­ness of the phar­ma in­dus­try.

EF­PIA’s op­po­si­tion to the changes has lin­gered since the be­gin­ning, and its lat­est es­ti­mate is that the rewrit­ten leg­is­la­tion could cost the in­dus­try €640 mil­lion ($688 mil­lion).

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN